NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Yatharth Hospital Q4 FY26 Revenue Surges 47% YoY to ₹3,416 Mn; EBITDA Up 37%
Yatharth Hospital delivered a robust Q4 FY26 performance with revenue growing 47% YoY to ₹3,416 million, supported by strong traction in newer hospitals which now contribute 22% of total revenue. While reported EBITDA margins dipped to 23.4% due to ramp-up costs, the adjusted EBITDA margin remained high at 30.4%. The company continues its expansion momentum with a new 250-bed Gurugram facility set to open in early FY27. Operational efficiency improved as debtor days reduced to 112 and cash conversion reached 98%.
முக்கிய அம்சங்கள்
Q4 FY26 Revenue grew 47% YoY to ₹3,416 Mn, while full-year FY26 revenue rose 36% to ₹12,072 Mn.Adjusted EBITDA margin (excluding ramp-up losses) stood at 30.4%, with reported EBITDA up 37% YoY to ₹799 Mn.Group ARPOB increased 5% YoY to ₹33,283, led by Noida Extension at ₹47.8k and Greater Noida at ₹40.3k.Newer hospitals in Delhi, Faridabad, and Agra contributed ₹753 Mn, representing 22% of the Group's quarterly revenue.Strong balance sheet management with a 98% cash conversion ratio and debtor days improving from 125 to 112.
👀 கவனிக்க வேண்டியவை
Investors should view the strong revenue growth and successful integration of new assets as a positive sign for long-term scalability. Monitor the upcoming Gurugram facility launch and the stabilization of margins as newer hospitals reach maturity.
Yatharth Hospital FY26 Revenue Up 30% to ₹5,919 Mn; Q4 PAT Rises 8.5% YoY
Yatharth Hospital reported a strong 29.6% growth in standalone revenue for FY26, reaching ₹5,918.84 million compared to ₹4,564.84 million in FY25. While top-line growth was robust, annual net profit growth was more modest at 8.8%, totaling ₹954.10 million, impacted by higher operational and finance costs. For Q4 FY26, revenue surged 45.6% YoY to ₹1,638.71 million, though PAT growth was limited to 8.5% YoY. The company's equity base strengthened significantly, with other equity rising to ₹15,232.24 million.
முக்கிய அம்சங்கள்
Standalone Revenue for FY26 grew 29.6% YoY to ₹5,918.84 million.Q4 FY26 Revenue increased significantly by 45.6% YoY to ₹1,638.71 million.Annual Net Profit (PAT) for FY26 stood at ₹954.10 million, up 8.8% from ₹876.92 million.Finance costs spiked to ₹57.31 million in FY26 from just ₹6.16 million in the previous year.Depreciation and amortization expenses rose to ₹304.59 million in FY26 versus ₹186.63 million in FY25.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's ability to convert high revenue growth into better bottom-line margins as new capacities stabilize. The significant jump in depreciation and finance costs suggests recent capital expenditure which warrants a watch on occupancy rates.
Yatharth Hospital Shareholders Approve Creation of Security with 99.99% Majority
Shareholders of Yatharth Hospital have overwhelmingly approved a special resolution to create security by way of charge, mortgage, or hypothecation on company assets. The resolution, passed via postal ballot on May 12, 2026, received 99.99% votes in favor, representing approximately 6.74 crore shares. This approval under Section 180(1)(a) of the Companies Act allows the company to secure its borrowings against its assets, providing necessary flexibility for future capital requirements. Both promoters and institutional investors showed 100% support for the proposal.
முக்கிய அம்சங்கள்
Special resolution passed with 99.99% of total votes in favor (6,74,23,350 votes).100% support received from both Promoter Group and Public Institutional investors.Enables the company to create charges or mortgages on assets to secure future borrowings.Total votes polled represented 69.98% of the total outstanding shares of the company.The resolution was passed as a Special Resolution through a remote e-voting process.
👀 கவனிக்க வேண்டியவை
This is a routine enabling resolution that allows the company to leverage its assets for future financing. Investors should monitor subsequent announcements regarding specific debt tie-ups or expansion plans that this security creation will support.
Yatharth Hospital Acquires 250-Bed Hospital in Gurugram for INR 100 Crores
Yatharth Hospital has announced the acquisition of an under-construction 250-bed hospital in Sector 40, Gurugram, for a consideration of approximately INR 100 crores. The company plans an additional capital outlay of INR 100 crores to complete the project and install medical equipment, bringing the total investment to INR 200 crores. This acquisition marks the group's entry into the lucrative Gurugram market, strategically located near high-income residential hubs and the IGI airport. The move increases the company's total announced bed capacity to approximately 3,250 beds.
முக்கிய அம்சங்கள்
Acquisition of an under-construction 250-bed hospital in Sector 40, Gurugram for ~INR 100 croresAdditional ~INR 100 crores earmarked for project completion and medical equipment procurementTotal announced bed capacity for the group increases to ~3,250 bedsStrategic entry into the high-growth Gurugram healthcare market targeting domestic and international patientsFacility is located in a high-income catchment area with proximity to premium commercial districts
👀 கவனிக்க வேண்டியவை
This expansion into the high-margin Gurugram market is a significant growth lever; investors should monitor the project's completion timeline and its impact on overall ROCE.
Yatharth Hospital Seeks Shareholder Nod to Create Security on Assets up to ₹1,000 Crores
Yatharth Hospital has initiated a postal ballot to seek shareholder approval for creating charges, mortgages, or hypothecations on its assets. The special resolution, under Section 180(1)(a) of the Companies Act, 2013, proposes a limit of ₹1,000 crores to secure various debt instruments. This authorization will allow the company to secure term loans, debentures, and other credit facilities from banks and financial institutions. The move provides the board with the necessary flexibility to leverage company assets for future growth and operational funding.
முக்கிய அம்சங்கள்
Proposed limit for creation of security on movable and immovable assets is ₹1,000 crores.Approval sought via special resolution under Section 180(1)(a) of the Companies Act, 2013.Security to cover various instruments including Rupee loans, commercial papers, and foreign currency borrowings.Remote e-voting period is scheduled from April 13, 2026, to May 12, 2026.The resolution enables the board to secure both existing and future borrowings to support company undertakings.
👀 கவனிக்க வேண்டியவை
This is a standard enabling resolution that increases the company's capacity to secure debt for future requirements. Investors should monitor for subsequent announcements regarding specific expansion plans or capital expenditures that may utilize this ₹1,000 crore headroom.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Yatharth Hospital Q3 FY26 Revenue Surges 46% YoY to INR 321 Cr; New Units Scale Rapidly
Yatharth Hospital reported its highest-ever quarterly revenue of INR 3,205 million, marking a robust 46% YoY growth driven by existing facilities and a rapid scale-up of new hospitals in Delhi and Faridabad. The company achieved an adjusted EBITDA margin of 29.2% and a Net Profit of INR 431 million, up 41% YoY. Management highlighted that new facilities in Delhi and Faridabad Sector-20 contributed 9% to group revenue in their first full quarter with ARPOBs exceeding the group average. With the integration of the Agra hospital in February 2026 and a roadmap to reach 5,000 beds, the company maintains a strong growth trajectory.
முக்கிய அம்சங்கள்
Consolidated revenue grew 46% YoY to INR 3,205 million, with existing hospitals growing 33% YoY.New Delhi and Faridabad Sector-20 hospitals generated INR 279 million in their first full quarter of operations.Group ARPOB increased 10% YoY to INR 33,744, with Noida Extension reaching a record INR 44,000.Net Profit (PAT) increased 41% YoY to INR 431 million, while adjusted PAT surged 80% YoY.Maintains a strong balance sheet with a net cash position of approximately INR 200 crores as of December 31, 2025.
👀 கவனிக்க வேண்டியவை
Investors should monitor the successful integration of the Agra facility and the company's progress toward reducing government business mix to below 30%. The rapid breakeven of new units and aggressive expansion plans make it a high-growth contender in the regional healthcare space.
Yatharth Hospital Q3 FY26: Revenue Jumps 46% to ₹320 Cr, PAT Rises 41% to ₹43 Cr
Yatharth Hospital delivered a strong performance in Q3 FY26, with revenue growing 46% YoY to ₹3,205 million and PAT increasing 41% to ₹431 million. Operational efficiency improved as occupancy reached 67% and ARPOB grew 10% to ₹33,744. The company successfully ramped up its new Delhi and Faridabad facilities, which contributed 9% to the total revenue. Additionally, the integration of the newly acquired 250-bed Agra hospital from February 2026 is expected to be immediately accretive to the bottom line.
முக்கிய அம்சங்கள்
Revenue grew 46% YoY to ₹3,205 mn and EBITDA increased 35% YoY to ₹742 mn in Q3 FY26.Adjusted EBITDA margin (excluding new hospital ramp-up losses) stood at a robust 29.2%.Occupancy improved to 67% from 56% YoY, while ARPOB increased 10% YoY to ₹33,744.New Delhi and Faridabad Sec-20 hospitals generated ₹279 mn revenue in their first full quarter of operations.Integrated a 250-bed Agra hospital on Feb 1, 2026, acquired for ₹260 Cr to expand the UP footprint.
👀 கவனிக்க வேண்டியவை
The stock remains a strong growth play in the healthcare sector given its successful M&A execution and rapid ramp-up of new beds. Investors should monitor the margin trajectory as new hospitals reach optimal utilization.
Yatharth Hospital reported a robust 43% YoY growth in standalone revenue to ₹158.15 crore for Q3 FY26. While Net Profit grew 7.4% YoY to ₹23.89 crore, the company showed strong sequential momentum with PAT rising 15.7% QoQ. The company continues its aggressive expansion, acquiring a 150-bed hospital in Agra effective February 2026. Additionally, the release of provisional attachments by the Income Tax department on company assets provides significant regulatory relief.
முக்கிய அம்சங்கள்
Standalone Revenue from operations grew 43% YoY to ₹1,581.5 million.Standalone Profit After Tax (PAT) increased 7.4% YoY to ₹238.9 million.Acquired Shantived Institute of Medical Sciences in Agra with 150 operational beds (expandable to 250).Utilized ₹5,862.3 million of QIP proceeds for debt repayment, acquisitions, and medical equipment.Income Tax department released provisional attachments on properties, bank deposits, and cash balances.
👀 கவனிக்க வேண்டியவை
Investors should view the strong revenue growth and inorganic expansion as positive indicators for long-term scale. Monitor the margin trajectory as the new Agra facility integrates and the pending tax appeal progresses.
Yatharth Hospital Completes 100% Acquisition of Shantived Agra; Operations Start Feb 1
Yatharth Hospital has finalized the acquisition of a 100% stake in Shantived Institute of Medical Sciences, located in Agra, by executing a Share Purchase Agreement on January 29, 2026. This transaction follows the initial announcement made in September 2025 and marks a significant expansion of the company's footprint. Commercial operations at the newly acquired facility are scheduled to commence almost immediately on February 1, 2026. This rapid operationalization is expected to contribute to the company's revenue stream starting from the final quarter of the current fiscal year.
முக்கிய அம்சங்கள்
Executed Share Purchase Agreement (SPA) for the 100% acquisition of Shantived Institute of Medical Sciences, Agra.The acquisition process was completed following the initial disclosure on September 13, 2025.Commercial operations at the target hospital are set to begin on February 1, 2026.The move strengthens the company's presence in the Uttar Pradesh healthcare market.
👀 கவனிக்க வேண்டியவை
Investors should monitor the occupancy rates and margin profile of the new Agra facility as it begins operations. The immediate start of commercial activities is a positive sign for near-term revenue growth.
Yatharth Hospital Shareholders Approve Ramesh Krishnan as Independent Director with 92.76% Votes
Shareholders of Yatharth Hospital & Trauma Care Services Limited have approved the appointment of Mr. Ramesh Krishnan as an Independent Director for a five-year term effective from November 5, 2025. The special resolution was passed via postal ballot with 92.76% of the total votes cast in favor. While the promoter group voted unanimously in favor, there was notable dissent from public institutional investors, with 34.02% of their votes cast against the resolution. The appointment is now finalized following the submission of the scrutinizer's report.
முக்கிய அம்சங்கள்
Special resolution passed with 92.76% majority, totaling 6,33,89,981 votes in favor.Mr. Ramesh Krishnan appointed as Independent Director for a 5-year tenure ending November 4, 2030.Significant dissent observed from public institutions, with 34.02% (49.43 lakh votes) voting against the appointment.Promoter and promoter group cast 5.37 crore votes, representing 100% support for the resolution.Total voter turnout represented 70.91% of the outstanding shares eligible to vote.
👀 கவனிக்க வேண்டியவை
Investors should note the successful board strengthening but may want to investigate the reasons behind the 34% institutional dissent regarding this specific appointment. No immediate portfolio changes are required as this is a routine governance update.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
